Neonicotinoid insecticides, the most important class of synthetic neuroactive insecticides, are widely used to treat crops and livestock against a broad range of pests (1, 2) . Imidacloprid (IMI) [1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine] is a chlorinated analogue of nicotine and the first neonicotinoid registered for use as pesticide by the United States Environmental Protection Agency (US EPA). Since its introduction to the insecticide market in 1992, imidacloprid's use has been growing every year due to its selective toxicity and apparent safety for humans. Today, it accounts for 41.5 % of neonicotinoid use (2, 3) . Imidacloprid is classified as a "Group E" carcinogen, which means that there is no evidence of carcinogenicity in humans (4). Neonicotinoid insecticides act as agonists of insect nicotinic acetylcholine receptors (nAChRs), which play an important role in synaptic transmission in the central nervous system (5) . Due to structural differences between mammal and insect nAChRs and the higher binding affinity for insect nAChR, imidacloprid is considered a selective toxicant (6) (7) (8) . Its oral LD 50 in rats and mice is 450 and 131 mg kg -1 of body weight (bw), respectively (9) . Even though imidacloprid is mildly toxic to mammals, it may still affect their heart, kidney, and other organs and cause gastrointestinal irritation and neurological symptoms or even death. There are many reports indicating adverse effects of imidacloprid in mammals, such as teratogenic (10, 11) , mutagenic (12) , neurotoxic (13) (14) (15) , and immunotoxic effects (16, 17) . The toxicity of imidacloprid is dose-dependent, as reported by a study that evaluated effects of 30 days oral administration of 1/85 LD 50 and 1/120 LD 50 of imidacloprid on thyroid toxicity in female rats (18) and a study of haematological and biochemical parameters in male rats after oral administration of 0.125 LD 50 and 0.1 LD 50 of imidacloprid, which correspond to the levels found in and on treated cucumbers one hour and one day after the application of imidacloprid, respectively (19) .
In this mini-review, however, we focus on the current knowledge of adverse effects of imidacloprid on the reproductive and endocrine function as evidenced by recent animal studies.
REPRODUCTIVE TOXICITY
Studies conducted in male and female laboratory animals, mostly rats, have established that oral administration of imidacloprid could affect reproductive function, as summarised in Table 1 (20) (21) (22) (23) (24) (25) (26) (27) (28) . Subchronic and chronic exposure to different doses of imidacloprid can cause histological damage of the testicular tissue, changes in sperm morphology, increased sperm mortality and abnormality, decreased sperm count and motility, inhibited spermatogenesis, and reduced testosterone levels in male rats, all of which could lead to infertility (20) (21) (22) (23) (24) .
More specifically, studies in male rats by Bal et al. (20, 21) showed that a three-month exposure to imidacloprid doses lower than the no-observable-effect-level (NOEL), which is 5-10 mg kg -1 for rats, adversely affected their testicular function during early postnatal development and in adulthood. The elevated fatty acids and lipid peroxidation ↓ total epididymal sperm count ↓ sperm motility ↓ live sperm count ↑ sperm abnormalities (head and tail) ↑ γ-GT, LDH-x, SDH in testis ↓ T in plasma and testis ↓ 3ẞ-HSD, 17ẞ-HSD in testis ↑ LPO; ↓ GSH in testis ↓ CAT, SOD at 90 mg kg -1 in testis ↓ GPx and GST in testis histopathological alterations in testis and epididymis (LPO) accompanied by lower glutathione (GSH) levels in the testes of the exposed rats resulted in impaired fertility, as evidenced by increased germ cell apoptosis and fragmentation of seminal DNA, lower serum testosterone level and higher rate of sperm abnormalities. The authors associated these adverse effects with the induction of oxidative stress in the testes, which are particularly sensitive to oxidative damage due to the presence of polyunsaturated fatty acids. In female rats, Kapoor et al. (25) reported that exposure to imidacloprid (20 mg kg -1 day -1 ) for 90 days caused changes in the ovarian morphology, reduced its weight, and adversely affected serum follicle stimulating hormone (FSH), luteinizing hormone (LH), and progesterone levels. The authors also reported induced oxidative stress, evidenced by lower activity of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and GSH and increased LPO level. These studies were the first to suggest the mechanisms of adverse imidacloprid effects on male and female reproduction. Later research reported higher LPO and lower GSH levels, as well as lower CAT, SOD, GPx, and bw, corresponding to 1/10 and 1/5 of LD 50 ) for 28 days and confirmed that oxidative stress is the mechanism that leads to reproductive toxicity of imidacloprid (24) .
Reproductive toxicity of imidacloprid was also studied following in utero exposure of the female offspring of pregnant rats receiving 10 mg kg -1 bw of imidacloprid through the tail vein from gestation day 7 to 21 (26) . The offspring showed disrupted follicular development, lower oestradiol and progesterone levels, lower ovarian weight and diameter as well as decrease in the rate of successful mating and reduction in foetal number due to downregulation of ovarian DAX1 gene compared to controls.
In a two-generation, two-litter study in rats Suter et al. (27) reported no adverse effects on the reproductive function or birth defects of imidacloprid exposure before and during mating, gestation, and lactation. However, the authors found decreased body weight in mother rats and male and female offspring that was associated with reduced food consumption at dietary imidacloprid dose of 700 ppm (corresponding to 47 mg kg -1 bw day -1 ). In a three-generation reproductive study (28) oral administration of 20 mg kg -1 bw day -1 of imidacloprid affected body weight and food consumption and caused only minimal effects on the reproductive performance such as reduction in fertility index in the second and third generation.
Neurotoxicity as the consequence of imidacloprid exposure in utero has been investigated in rat offspring by Abou-Donia et al. (29) . Gestational exposure to a single large dose (0.75 of the LD 50 ) of imidacloprid caused developmental neurobehavioral deficits and increased the expression of glial fibrillary acidic protein (GFAP) in the brain regions of 30-day-old offspring with possible longterm adverse health effects. An in vitro investigation by Gu et al. (30) has shown adverse effects of direct exposure to imidacloprid on the sperm function and embryonic development that may also present a risk for human reproductive health.
Investigations in other laboratory animals showed no adverse effects of imidacloprid exposure on the early development of the zebrafish (Danio rerio) (31), but in male rabbits (Oryctolagus cuniculus) it was associated with testicular damage that can lead to infertility and reproductive disorders (32) .
ENDOCRINE DISRUPTION
Many pesticides, including imidacloprid, can affect the normal functioning of animal endocrine systems by interfering with natural hormones. Due to their strong affinity for oestrogen and androgen receptors, they can activate these receptors and mimic hormonal action or block the receptors and inhibit their action. In addition, endocrine disrupting pesticides can interfere with the synthesis, secretion, transport, metabolism, binding, or elimination of natural hormones (32) .
Some investigations imply that exposure to environmental endocrine disruptors could be the generative cause of obesity (34, 35) . This may also be true for endocrine disrupting pesticides. Imidacloprid's role in obesity was investigated in a study in which mice were exposed to low doses (0.5 % of the LD 50 ) of dithiocarbamate mancozeb and imidacloprid from postnatal day 1 to weaning (postnatal day 28) through lactating mother. The exposure to individual pesticides did not disrupt hormonal/metabolic homeostasis or affect body weight gain, but exposure to their combination did (36) . An in silico study by the same authors showed that imidacloprid and mancozeb disrupted steroid hormone biosynthesis by impairing the activities of the cytochrome P450 (CYP) enzymes that have a key role in the synthesis and breakdown of various steroid hormones (37) . Several studies have shown that imidacloprid potentiates adipogenesis in 3T3-L1 adipocytes and induces insulin resistance in C2C12 myotubes (38, 39) . The same group of authors reported that oral exposure to low doses (0.6 and 6 mg kg -1 bw day -1 ) of imidacloprid for 12 weeks in male and female C57BL/6J mice enhanced high fat-diet adiposity by mechanisms that still need to be clarified. Insulin resistance observed in male mice was not confirmed in females, which was explained by potential sex differences (40, 41) .
CONCLUSION
Animal study evidence is pretty clear about the risks involved in imidacloprid exposure for male and female reproduction. It may alter essential reproductive functions by affecting hormone levels and cause reproductive organ disruption and suppression of their function, which may lead to infertility. In utero exposure to imidacloprid can significantly affect offspring development with lasting adverse consequences in adulthood. The European Commission has restricted the use of imidacloprid and two other neonicotinoids since 2013 due to their potential role in the collapse of the bee population (42) . The updated risk assessment report regarding neonicotinoids was issued by the European Food Safety Authority in February 2018 (43) . Although it points to risks for honeybees, the decision regarding a possible EU-wide ban of neonicotinoids was not made and remains the responsibility of the European Commission and Member state authorities. Nevertheless, since imidacloprid is still widely used, more measures should be taken to minimise its adverse effects.
Imidakloprid kao reprodukcijski toksikant i endokrini disruptor: istraživanja na laboratorijskim životinjama
Imidakloprid, neonikotinoidni insekticid, koristi se diljem svijeta zbog svoje selektivne toksičnosti za insekte. S obzirom na to da njegovi ostaci mogu ući u hranidbeni lanac, važno je istražiti potencijalno štetne učinke izloženosti imidaklopridu. U ovom preglednom radu prikazani su podaci o reprodukcijskoj toksičnosti imidakloprida i njegovim učincima kao hormonskog otrova u laboratorijskih životinja. Istraživanja koja su provedena uglavnom na laboratorijskim štakorima pokazala su štetne učinke imidakloprida na reprodukciju roditelja i potomstva, kao i na razvoj potomstva. Poput mnogih pesticida, imidakloprid može djelovati i kao hormonski otrov te poremetiti ne samo metaboličku ravnotežu i pridonijeti povećanju pretilosti nego i steroidogenezu inhibicijom aktivnosti sustava enzima citokrom P-450 (CYP). Svi ti štetni učinci imidakloprida mogu predstavljati ozbiljan rizik za reprodukciju i razvoj s dugoročnim štetnim posljedicama u odrasloj dobi.
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